Antiplatelets and Intramyocardial Hemorrhage in STEMI: Incidence and Outcomes
NCT06851325
Acute Myocardial Infarction, Cardiovascular Diseases
Indianapolis, Indiana, United States
View Trial DetailsNCT Number: NCT03749694
The aim of the study was to use data from the Myocardial Ischaemia National Audit Project (MINAP) to investigate whether temporal improvements in survival were associated with changes in patients' baseline clinical risk or use of guideline-indicated treatments for the management of STEMI, and to determine the extent to which associations explained the temporal improvements in survival.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: one year
Time frame: six months
University of Leeds
Other
Investigating Temporal Improvements in Survival Following ST-elevation Myocardial Infarction: A Causal Mediation Analysis Using the Myocardial Ischaemia National Audit Project, 2004-2013.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06851325
Acute Myocardial Infarction, Cardiovascular Diseases
Indianapolis, Indiana, United States
View Trial DetailsNCT03470441
Acute Myocardial Infarction, Cardiovascular Diseases
Minneapolis, Minnesota, United States
View Trial DetailsNCT04837001
Acute Myocardial Infarction, Cardiovascular Diseases
Torrance, California, United States
View Trial DetailsNCT05872308
Acute Myocardial Infarction, Cardiovascular Diseases
Indianapolis, Indiana, United States
View Trial Details